Deep Intelligent Pharma Unleashes a New Era of AI-Driven Drug Development at Microsoft Build 2025
Seattle, United States — Deep Intelligent Pharma (DIP) has officially launched a groundbreaking generative AI platform that promises to redefine how the world develops medicine. Continue Reading

